About this document

Capromorelin Efficacy in CKD Cats by Leila Sena is a document available to read on EtoBox.

The study evaluated the efficacy and safety of capromorelin in promoting weight gain in cats with chronic kidney disease (CKD) and unintended weight loss through a randomized, placebo-controlled trial involving 176 cats. Results showed a significant increase in body weight for the capromorelin group compared to placebo, with a mean change of +5.18% versus -1.65%, indicating capromorelin

Author

Leila Sena

Language

EN